PHILADELPHIA—Acute kidney injury (AKI), also known as acute renal failure, requiring dialysis has become more common than end-stage renal disease (ESRD) requiring renal replacement therapy (RRT), according to findings presented at Kidney Week 2011.
Close supervision by rheumatologists and the use of immunosuppressant drugs appear to improve the survival of lupus patients with end-stage renal disease. John Schieszer reports in today’s Medical Minute that this new research finding could reverse a long-standing clinical practice for nephrologists.
As of December 31, 2009, the United States had 571,414 end-stage renal disease (ESRD) patients, up 3.8% from 549,265 patients a year before, according to the 2011 U.S. Renal Data System Annual Data Report.
PRAGUE—Two forms of renal replacement therapy (RRT) for end-stage renal disease are associated with similar rates of mortality overall and from cardiovascular (CV) causes, according to a new study.
Those with phosphate levels in the highest two quartiles progressed significantly faster either to end-stage renal disease (ESRD) or to a composite endpoint of a doubling of serum creatinine.
Frequent follow-up with a rheumatologist and continued immunosuppressive treatment for systemic lupus erythematosus (SLE) in patients with end-stage renal disease (ESRD) improves their chances of survival, according to a study.
End-stage renal disease (ESRD) is more likely to develop in adolescents and young adults with persistent microscopic hematuria, according to a report in the Journal of the American Medical Association (2011;306:729-736).
The Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule that would update payment policies and rates under the End-Stage Renal Disease (ESRD) Prospective Payment System.
Elevated levels of fibroblast growth factor 23 (FGF-23) is an independent risk factor for end-stage renal disease (ESRD) in patients with relatively preserved kidney function and for mortality across the spectrum of chronic kidney disease (CKD).
PRAGUE—End-stage renal disease patients who start on peritoneal dialysis (PD) rather than hemodialysis (HD) spend less time on a renal transplant waiting list before getting a kidney, new findings suggest.
